CA964582A - Combination of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson's disease - Google Patents

Combination of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson's disease

Info

Publication number
CA964582A
CA964582A CA131,414A CA131414A CA964582A CA 964582 A CA964582 A CA 964582A CA 131414 A CA131414 A CA 131414A CA 964582 A CA964582 A CA 964582A
Authority
CA
Canada
Prior art keywords
dopa
imino
phenyl
disease
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA131,414A
Other languages
English (en)
Other versions
CA131414S (en
Inventor
Nicholas P. Plotnikoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of CA964582A publication Critical patent/CA964582A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA131,414A 1971-01-27 1971-12-30 Combination of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson's disease Expired CA964582A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11025371A 1971-01-27 1971-01-27

Publications (1)

Publication Number Publication Date
CA964582A true CA964582A (en) 1975-03-18

Family

ID=22332021

Family Applications (1)

Application Number Title Priority Date Filing Date
CA131,414A Expired CA964582A (en) 1971-01-27 1971-12-30 Combination of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson's disease

Country Status (6)

Country Link
US (1) US3686409A (Direct)
AU (1) AU461236B2 (Direct)
CA (1) CA964582A (Direct)
DE (1) DE2203584A1 (Direct)
FR (1) FR2123479B1 (Direct)
GB (1) GB1330993A (Direct)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7071211B2 (en) * 2002-09-27 2006-07-04 Bausch & Lomb Inc. Small organic molecules that increase the activity of gelatinase a in ocular cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108045A (en) * 1960-03-22 1963-10-22 Purdue Frederick Co Metal chelates of oxazolidinones as central nervous system stimulants

Also Published As

Publication number Publication date
AU3771772A (en) 1973-07-12
US3686409A (en) 1972-08-22
FR2123479A1 (Direct) 1972-09-08
AU461236B2 (en) 1975-05-22
DE2203584A1 (de) 1972-08-03
GB1330993A (en) 1973-09-19
FR2123479B1 (Direct) 1975-02-07

Similar Documents

Publication Publication Date Title
AU459240B2 (en) Improvements in or relating tothe production of titanium
ZA722581B (en) Improvements in and relating to the manufacture of pigments
ZA732235B (en) Improvements relating to the treatment of cereals and other seeds
CA994671A (fr) Compositions et procede pour ameliorer l'apparence de la peau et chevelure
AU465568B2 (en) Improvement in or relating to methods of seed treatment and apparatus therefor
AU465949B2 (en) N-TERTIARY-4'-AMINOMETHYL-DIBENZO b,e-11-OXEPINE-2'-SPIRO-1',3'-DIOXOLANES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC APPLICATION
AU458386B2 (en) Improvements in or relating tothe treatment of diseases ofthe skin and mucosa
CA963204A (en) Treatment of pigments
AU471474B2 (en) Method and compositions forthe treatment of human hair
CA987321A (fr) Isopropyl-2-tetrahydro oxazines-1,3 substituees, leur procede de preparation et leur application en therapeutique
AU472168B2 (en) Treatment of titanium
CA964582A (en) Combination of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson's disease
AU452550B2 (en) The use of diphenylsulfones inthe treatment of mareks disease
AU458749B2 (en) Process for the treatment and care of dentures
CA922691A (en) Process for the preparation of 21-deoxy-21-n-/n' -methylpiperazinyl/ -prednisolone and salts
CS164401B1 (en) Method of 1-beta-d-arabinofuranosylcytosine's preparation
CA981612A (en) Process for the preparation of l-dopa and l-m-tyrosine and intermediates intended to be used at such a process
AU464446B2 (en) Improvements in and relating to apparatus for the treatment of pigments
AU470527B2 (en) PROCESS FORTHE PREPARATION OF 1, 5 and 1, 8-DIHYDROXY-ANTHRAGUINONES
ZA74404B (en) 4,8-dimethoxy-furo(3',2'-f)benzoxazol-2-yl acethydroxamic acid,its process of preparation and its therapeutic application
CA919686A (en) Prophylaxis and treatment of cardiac disorders
AU436023B2 (en) Treatment of marek's disease
ZA71461B (en) Method of treating parkinson's disease
AU479644B2 (en) Improvements in and relating tothe treatment of pigments
AU1237170A (en) Treatment of marek's disease